Early effects of tumour necrosis factor α blockade on skin and synovial tissue in patients with active psoriasis and psoriatic arthritis

Background: Tumour necrosis factor α (TNFα) blockade using infliximab, a chimeric anti-TNFα antibody, is an effective treatment for both psoriasis and psoriatic arthritis (PsA). Objective: To analyse the early effects of infliximab treatment on serial skin and synovial tissue biopsy samples. Methods...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Goedkoop, A, Kraan, M, Teunissen, M, Picavet, D, de Rie, M A, Bos, J, Tak, P
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2004
Soggetti:
Extended Report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC1755073/
https://ncbi.nlm.nih.gov/pubmed/15194570
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2003.018085
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi